Sygnature Discovery Revenue and Competitors

Nottingham, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Sygnature Discovery's estimated annual revenue is currently $125.2M per year.(i)
  • Sygnature Discovery's estimated revenue per employee is $201,000

Employee Data

  • Sygnature Discovery has 623 Employees.(i)
  • Sygnature Discovery grew their employee count by 19% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.1M25912%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$112.8M5613%N/AN/A
#4
$21.9M10931%N/AN/A
#5
$34M16923%N/AN/A
#6
$59.5M296-4%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$7.8M3926%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

Sygnature Discovery - enabling success in drug discovery Sygnature Discovery (www.sygnaturediscovery.com ) is a leading independent provider of integrated drug discovery resource and expertise. Since 2011, 27 compounds discovered by Sygnature for clients have entered pre-clinical development and so far 14 of these have progressed to clinical trials (Phases I, II and III). We add considerable value to our clients' research projects by providing intellectual input and drug discovery expertise to accelerate target validation, hit identification, hit-to-lead, lead optimisation and drug discovery programmes. Sygnature's capabilities include medicinal chemistry, in vitro biology, computational chemistry and informatics, DMPK, and protein crystallography (via affiliate company Peak Proteins). We have long-term partners that provide pre-clinical experimental services support. Sygnature Discovery operates a business whose primary focus is value creation for our clients, through the application of integrated drug discovery know-how and close working relationships. We have built a team of over 200 pharmaceutical industry-experienced research scientists (over 80% PhD qualified) with the ability to collaborate on an equal footing with our clients scientists to drive drug discovery projects towards the clinic. In summary, Sygnature Discovery offers: Target validation Hit identification Hit-to-lead Lead optimisation Integrated drug discovery programmes Medicinal chemistry In vitro biology (including biophysics and live cell imaging) Computational chemistry DMPK Protein crystallography

keywords:N/A

N/A

Total Funding

623

Number of Employees

$125.2M

Revenue (est)

19%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sygnature Discovery News

2022-04-17 - Ligand Binding Assay Market Size, Share, Forecast 2022 ...

Sygnature Discovery; Shanghai Medicilon Inc; Intertek Group plc; PerkinElmer Inc; Charles River; Alliance Pharma; Eurofins Discovery; Creative...

2022-04-17 - Fragment-Based Drug Discovery Market Research Report ...

Market Strides published report titled Fragment-Based Drug Discovery Market By Type, By Application, Regional Analysis, Growth Opportunity and...

2022-04-17 - Global Phenotypic Drug Discovery Market 2022 – Analysis By ...

The vendors that are covered in the global market: Eurofins Discovery; Sygnature Discovery; PsychoGenics; siTOOLs Biotech; PhoreMost; Charles...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$193.8M6832%N/A
#2
$124.3M68616%N/A
#3
$75M75011%N/A
#4
$151.8M83443%N/A
#5
$328.9M8707%N/A